Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Zerbato

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Lancet. HIV|March 15, 2020
A cure for HIV: how would we know?Jennifer M Zerbato, Sharon R Lewin
Antimicrobial Agents and Chemotherapy|December 21, 2016
Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4<sup>+</sup> T Cells following Latency ReversalJennifer M Zerbato, Gilda Tachedjian, Nicolas Sluis-Cremer
Current Opinion in Virology|May 4, 2019
Between a shock and a hard place: challenges and developments in HIV latency reversalJennifer M Zerbato, Harrison V Purves, Sharon R Lewin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2011
Enhancement of antibody class-switch recombination by the cumulative activity of four separate elementsWesley A Dunnick, Jian Shi, Jennifer M Zerbato, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2019
Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1Jennifer M Zerbato, Deborah K McMahon, Michelle D Sobolewski, et al.
Journal of Virology|July 1, 2016
Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In VitroJennifer M Zerbato, Erik Serrao, Gina Lenzi, et al.
Retrovirology|October 7, 2015
Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchNarasimhan J Venkatachari, Jennifer M Zerbato, Siddhartha Jain, et al.
Pathology|July 1, 2022
Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR)Priyank Rawat, Jennifer M Zerbato, Ajantha Rhodes, et al.
Journal of Virology|August 2, 2022
Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected IndividualsXiao Qian Wang, Jennifer M Zerbato, Anchalee Avihingsanon, et al.
Frontiers in Neurology|April 17, 2025
Follow up rates and patient interest in clinical care after mild traumatic brain injury presenting to a level 1 trauma center: a TRACK-TBI prospective cohort studyShawn R Eagle, Jason Barber, Nancy Temkin, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Lancet. HIV|March 15, 2020
A cure for HIV: how would we know?Jennifer M Zerbato, Sharon R Lewin
Antimicrobial Agents and Chemotherapy|December 21, 2016
Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4<sup>+</sup> T Cells following Latency ReversalJennifer M Zerbato, Gilda Tachedjian, Nicolas Sluis-Cremer
Current Opinion in Virology|May 4, 2019
Between a shock and a hard place: challenges and developments in HIV latency reversalJennifer M Zerbato, Harrison V Purves, Sharon R Lewin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2011
Enhancement of antibody class-switch recombination by the cumulative activity of four separate elementsWesley A Dunnick, Jian Shi, Jennifer M Zerbato, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2019
Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1Jennifer M Zerbato, Deborah K McMahon, Michelle D Sobolewski, et al.
Journal of Virology|July 1, 2016
Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In VitroJennifer M Zerbato, Erik Serrao, Gina Lenzi, et al.
Retrovirology|October 7, 2015
Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchNarasimhan J Venkatachari, Jennifer M Zerbato, Siddhartha Jain, et al.
Pathology|July 1, 2022
Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR)Priyank Rawat, Jennifer M Zerbato, Ajantha Rhodes, et al.
Journal of Virology|August 2, 2022
Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected IndividualsXiao Qian Wang, Jennifer M Zerbato, Anchalee Avihingsanon, et al.
Frontiers in Neurology|April 17, 2025
Follow up rates and patient interest in clinical care after mild traumatic brain injury presenting to a level 1 trauma center: a TRACK-TBI prospective cohort studyShawn R Eagle, Jason Barber, Nancy Temkin, et al.
Pageof 3